Pathophysiology of pediatric heart failure
Progress in Pediatric Cardiology, ISSN: 1058-9813, Vol: 11, Issue: 3, Page: 175-184
2000
- 23Citations
- 17Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Metrics Details
- Citations23
- Citation Indexes23
- 23
- CrossRef18
- Captures17
- Readers17
- 17
Article Description
Our understanding of the syndrome of heart failure has undergone several revisions, most importantly in the second half of the 20th century. New insights into the mechanisms of diseases offer new, challenging, controversial and sometimes counterintuitive forms of therapy. The development and progression of heart failure results from a complex interplay of hemodynamic and neurohormonal, cellular and genetic factors, rather than simply changes in cardiac function. It is because of this reason that our therapeutic focus can no longer be solely based on supply and demand models. Since the description of the pulsatile nature of the heart function and the flow of blood around a circuit by W. Harvey, numerous new paradigms have been put forward to explain the nature of heart failure. However, no single new model thus far proposed has been able to displace previous ones and successfully dictate therapy. It is the purpose of this manuscript to review the overall current understanding of the heart failure syndrome and how these new ideas may affect our therapeutic approach.
Bibliographic Details
http://www.sciencedirect.com/science/article/pii/S1058981300000485; http://dx.doi.org/10.1016/s1058-9813(00)00048-5; http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=0033823271&origin=inward; http://www.ncbi.nlm.nih.gov/pubmed/10978710; http://linkinghub.elsevier.com/retrieve/pii/S1058981300000485; http://api.elsevier.com/content/article/PII:S1058981300000485?httpAccept=text/xml; http://api.elsevier.com/content/article/PII:S1058981300000485?httpAccept=text/plain; https://linkinghub.elsevier.com/retrieve/pii/S1058981300000485
Elsevier BV
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know